LEGISLATURE
It’s the bill known as the Consolidated Appropriations Act, 2026 (H.R. 7148). House Passes HR 7148, Advancing New PBM Transparency and Compensation Rules | Troutman Pepper Locke - JDSupra Here’s a link to the bill text… https://www.congress.gov/bill/119th-congress/house-bill/7148 looks like it’s Buddy Carter’s bill. That’s great. MSN Shout out to the pharmacists!!! Great work, you guys. https://www.youtube.com/watch?v=3lsPNR-boqM
DEPT OF LABOR
via Keith SonderlingKeith Sonderling • 2ndVerified • 2ndUnited States Deputy Secretary of Labor
The U.S. Department of Labor issued a landmark proposed regulation designed to bring overdue transparency to the fees and compensation 𝘗𝘩𝘢𝘳𝘮𝘢𝘤𝘺 𝘉𝘦𝘯𝘦𝘧𝘪𝘵 𝘔𝘢𝘯𝘢𝘨𝘦𝘳𝘴 (𝘗𝘉𝘔) receive. The proposed regulation is the most significant federal reform of prescription drug middlemen proposed in decades.
The proposed rule would require pharmacy benefit managers to make disclosures to plan fiduciaries that would allow them to assess the reasonableness of compensation for the services under the law.
The proposed rule requires PBMs to disclose the following information for the first time:
•Rebates and other payments from drug manufacturers.
•Compensation received when the price paid by the plan for a prescription drug exceeds the amount reimbursed to the pharmacy.
•Payments recouped from pharmacies in connection with prescription drugs dispensed to the plan.
The proposed regulation would also allow plan fiduciaries to audit the accuracy of PBM disclosures and provides additional relief for plan fiduciaries if their PBM fails to meet its obligation.
By lowering drug costs, the Trump administration is putting money back in the pockets of American workers and retirees, their families, and businesses.
𝗖𝗼𝗺𝗺𝗲𝗻𝘁𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗽𝗿𝗼𝗽𝗼𝘀𝗮𝗹 𝗮𝗿𝗲 𝗱𝘂𝗲 𝟲𝟬 𝗱𝗮𝘆𝘀 𝗳𝗿𝗼𝗺 𝗶𝘁𝘀 𝗝𝗮𝗻. 𝟯𝟬 𝗽𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝘁𝗵𝗲 𝗙𝗲𝗱𝗲𝗿𝗮𝗹 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿: LinkedIn
Activate to view larger image,
FTC
We are still waiting for this…summer at the latest, I promise.